Federal Register / Vol. 77, No. 33 / Friday, February 17, 2012 / Notices 9665 

Amount of the Award(s): Up to 

$196,506 per grantee over a one-year 

project period. 

CFDA Number: 93.110. 

Current Project Period: 7/1/2007 

through 6/30/2012. 

Period of Supplemental Funding: 

7/1/2012 through 6/30/2013. 

Authority: Title V of the Social Security 

Act, Section 501(a)(2) (42 U.S.C. 701(a)(2)). 

Justification 

HRSA is extending funding for the 

Leadership Training in Pediatric 

Dentistry grants by one year for the 

following reason: MCHB has been 

working with leaders within HRSA 

involved in oral health, the Bureau of 

Health Professions (BHPr) on oral health 

training investments, and other oral 

health leaders in the field to align its 

leadership training in oral health with 

HRSA’s other oral health training 

investments. With HRSA prioritizing 

oral health integration in primary care, 

MCHB is focusing on the best possible 

use of its funds to continue to promote 

oral health training in a coordinated 

way related to efforts and initiatives 

within HRSA and the field. 

HRSA’s BHPr plans to hold a 

stakeholders meeting on oral health 

training in 2012 that would impact the 

scope and nature of all HRSA’s oral 

health training initiatives. To ensure 

coordinated and non-duplicative HRSA 

program planning and future oral health 

grant funding, it is crucial to fund 

MCHB’s current training program for 

one year to sustain MCH oral health 

leadership training, while developing 

the next MCH oral health leadership 

training initiative in a systemically 

coordinated way with other HRSA oral 

health training initiatives. 

FOR FURTHER INFORMATION CONTACT: 

Christopher Dykton, Health Resources 

and Services Administration, Maternal 

and Child Health Bureau, 5600 Fishers 

Lane, Room 18A–55, Rockville, 

Maryland 20857 or email 

cdykton@hrsa.gov. 

Dated: February 10, 2012. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2012–3792 Filed 2–16–12; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Emergency 

Review; Comment Request: A MultiCenter International Hospital-Based 

Case-Control Study of Lymphoma in 

Asia (AsiaLymph) (NCI) 

Summary: In accordance with Section 

3507(j) of the Paperwork Reduction Act 

of 1995, the National Cancer Institute 

(NCI), the National Institutes of Health 

(NIH), has submitted to the Office of 

Management and Budget (OMB) a 

request for emergency review and 

processing this information collection 

by March 5, 2012. NCI is requesting 

emergency processing of this 

information collection, pursuant to 5 

CFR 1320.13, because NCI cannot 

reasonably comply with the normal 

clearance procedures which would 

cause a delay and likely prevent or 

substantially disrupt the collection of 

information. A delay in starting the 

information collection would hinder the 

agency in accomplishing its mission to 

the detriment of the public good. Public 

harm could result through the loss of 

critically needed information to 

understand and reduce the cancer 

burden from lymphoid malignancies in 

the Asian population. The National 

Institutes of Health may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Proposed Collection: Title: A MultiCenter International Hospital-Based 

Case-Control Study of Lymphoma in 

Asia (AsiaLymph) (NCI). Type of 

Information Collection Request: 

Emergency. Need and Use of 

Information Collection: Incidence rates 

of certain lymphomas have increased in 

several centers in Asia thereby 

increasing the cancer burden in these 

populations, but the causes remain 

unknown. AsiaLymph is a multidisciplinary case-control study that will 

confirm and extend previous findings 

and yield novel insights into the causes 

of lymphoma in both Asia and the West. 

The major postulated risk factors for 

evaluation in this study are chemical 

exposures (i.e., organochlorines, 

trichloroethylene, and benzene) and 

genetic susceptibility. Other factors 

potentially related to lymphoma, such 

as viral infections, ultraviolet radiation 

exposure, medical conditions, and other 

lifestyle factors will also be studied. 

Patterns of key risk factors, including 

range of exposures, prevalence of 

exposures, correlations between 

exposures, and variation in gene regions 

are of particular interest. Patients from 

19 participating hospitals will be 

screened and enrolled. There will be a 

one-time computer-administered 

interview, and patients will also be 

asked to provide a one-time blood and 

buccal cell mouth wash sample and 

lymphoma cases will be asked to make 

available a portion of their pathology 

sample. Frequency of Response: Once. 

Affected Public: Individuals. Type of 

Respondents: Newly diagnosed patients 

with lymphoma or patients undergoing 

surgery or other treatment for noncancer related medical issues who live 

in Hong Kong, Taiwan, and Chengdu 

and Tianjin, China will be enrolled at 

treating hospitals. The annual reporting 

burden is estimated at 3,377 hours (see 

Table below). There are no Capital 

Costs, Operating Costs, and/or 

Maintenance Costs to report. 

ESTIMATES OF ANNUAL BURDEN HOURS

Category of 

respondents Types of respondents Number of respondents 

Frequency of 

response 

Average time 

per response 

(Hours) 

Annual burden 

hours 

Individuals ......... Patients to be Screened ................................................... 3,100 1 5/60 258 

Patients with Lymphoma .................................................. 1,100 1 105/60 963 

Other Patients ................................................................... 1,100 1 105/60 963 

Study Pathologists ............................................................ 19 58 5/60 92 

Interviewers ...................................................................... 19 116 30/60 1102 

Total ........... ........................................................................................... ........................ ........................ ........................ 3,377 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

mstockstill on DSK4VPTVN1PROD with NOTICES

9666 Federal Register / Vol. 77, No. 33 / Friday, February 17, 2012 / Notices 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact 

Nathaniel Rothman, Senior Investigator 

for the Occupational and Environmental 

Epidemiology Branch, Division of 

Epidemiology and Genetics, National 

Cancer Institute, 6120 Executive 

Boulevard, Room 8118, Rockville, MD 

20892 or call non-toll-free number 301– 

496–9093 or email your request, 

including your address to: 

rothmann @mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 15 days of the date of 

this publication. 

Dated: February 13, 2012. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2012–3830 Filed 2–16–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; New Proposed 

Collection; Comment Request Stress 

and Cortisol Measurement for the 

National Children’s Study 

Summary: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Institute of Child Health and 

Human Development (NICHD), the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection 

Title: Stress and Cortisol 

Measurement Substudy for the National 

Children’s Study (NCS). Type of 

Information Collection Request: NEW. 

Need and Use of Information Collection: 

The Children’s Health Act of 2000 (Pub. 

L. 106–310) states: 

(a) PURPOSE.—It is the purpose of this 

section to authorize the National Institute of 

Child Health and Human Development to 

conduct a national longitudinal study of 

environmental influences (including 

physical, chemical, biological, and 

psychosocial) on children’s health and 

development. 

(b) IN GENERAL.—The Director of the 

National Institute of Child Health and 

Human Development shall establish a 

consortium of representatives from 

appropriate Federal agencies (including the 

Centers for Disease Control and Prevention, 

the Environmental Protection Agency) to— 

(1) Plan, develop, and implement a 

prospective cohort study, from birth to 

adulthood, to evaluate the effects of both 

chronic and intermittent exposures on child 

health and human development; and 

(2) Investigate basic mechanisms of 

developmental disorders and environmental 

factors, both risk and protective, that 

influence health and developmental 

processes. 

(c) REQUIREMENT.—The study under 

subsection (b) shall— 

(1) Incorporate behavioral, emotional, 

educational, and contextual consequences to 

enable a complete assessment of the physical, 

chemical, biological, and psychosocial 

environmental influences on children’s wellbeing; 

(2) Gather data on environmental 

influences and outcomes on diverse 

populations of children, which may include 

the consideration of prenatal exposures; and 

(3) Consider health disparities among 

children, which may include the 

consideration of prenatal exposures. 

To fulfill the requirements of the 

Children’s Health Act, the Stress and 

Cortisol Measurement Substudy will 

develop an optimized, item-reduced 

measure of self-reported stress that is 

supported empirically through 

convergent validity analysis of stress 

biomarkers. Specifically, key 

moderators of stress biomarkers will be 

evaluated to inform the efficiency and 

quality of measurements during 

pregnancy. Development of a 

scientifically robust maternal stress 

measure would measure chronic stress 

more efficiently, would not require 

biospecimen collection and biomarker 

analyses, and would thereby reduce 

participant burden and NCS Vanguard 

(Pilot) and NCS Main Study costs. With 

this information collection request, the 

NCS seeks to obtain OMB’s clearance to 

conduct a substudy aimed at developing 

a validated questionnaire that will 

reflect specific biological and 

physiological measures of maternal 

stress. 

Background 

The National Children’s Study is a 

prospective, national longitudinal study 

of the interaction between environment, 

genetics on child health and 

development. The Study defines 

‘‘environment’’ broadly, taking a 

number of natural and man-made 

environmental, biological, genetic, and 

psychosocial factors into account. By 

studying children through their 

different phases of growth and 

development, researchers will be better 

able to understand the role these factors 

have on health and disease. Findings 

from the Study will be made available 

as the research progresses, making 

potential benefits known to the public 

as soon as possible. The National 

Children’s Study is led by a consortium 

of federal partners: the U.S. Department 

of Health and Human Services (http:// 

www.hhs.gov/) (including the Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development 

(http://www.nichd.nih.gov/) and the 

National Institute of Environmental 

Health Sciences (http:// 

www.niehs.nih.gov/) of the National 

Institutes of Health (http:// 

www.nih.gov/) and the Centers for 

Disease Control and Prevention (http:// 

www.cdc.gov/)), and the U.S. 

Environmental Protection Agency 

(http://www.epa.gov/). 

To conduct the detailed preparation 

needed for a study of this size and 

complexity, the NCS was designed to 

include a preliminary pilot study 

known as the Vanguard Study. The 

purpose of the Vanguard Study is to 

assess the feasibility, acceptability, and 

cost of the recruitment strategy, study 

procedures, and outcome assessments 

that are to be used in the NCS Main 

Study. The Vanguard Study begins prior 

to the NCS Main Study and will run in 

parallel with the Main Study. At every 

phase of the NCS, the multiple 

methodological studies conducted 

during the Vanguard phase will inform 

the implementation and analysis plan 

for the Main Study. 

In this information collection request, 

the NCS requests approval from OMB to 

perform a multi-center substudy, called 

the Stress and Cortisol Measurement 

Substudy. This substudy aims to 

mstockstill on DSK4VPTVN1PROD with NOTICES